The Enterprise Value as of November 2024 (TTM) for Nexalin Technology, Inc. (NXL) is 28.95M

According to Nexalin Technology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 28.95M. This represents a change of 273.18% compared to the average of 7.76M of the last 4 quarters.

Nexalin Technology, Inc. (NXL) Historical Enterprise Value (quarterly & annually)

How has NXL Enterprise Value performed in the past?

The mean historical Enterprise Value of Nexalin Technology, Inc. over the last ten years is 11.85M. The current 28.95M Enterprise Value has changed 24.34% with respect to the historical average. Over the past ten years (40 quarters), NXL's Enterprise Value was at its highest in in the March 2022 quarter at 16.77M. The Enterprise Value was at its lowest in in the September 2022 quarter at -1495255.64.

Nexalin Technology, Inc. (NXL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nexalin Technology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nexalin Technology, Inc. (NXL) Average Enterprise Value

How has NXL Enterprise Value performed in the past?

The current Enterprise Value of Nexalin Technology, Inc. (NXL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nexalin Technology, Inc. (NXL) Enterprise Value vs. Peers

How is NXL’s Enterprise Value compared to its peers?

Nexalin Technology, Inc.’s Enterprise Value is greater than Ainos, Inc. (9.58M), less than Electromed, Inc. (175.81M), less than Armm Inc. (0), less than Surmodics, Inc. (544.88M), greater than Bluejay Diagnostics, Inc. (-6343730.00), greater than INVO Bioscience, Inc. (7.69M), greater than Motus GI Holdings, Inc. (-2499611.00), greater than IRIDEX Corporation (22.63M), less than Aziyo Biologics, Inc. (40.84M), greater than Ainos, Inc. (9.58M), less than LENSAR, Inc. (63.51M), less than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (2.99B), less than OrthoPediatrics Corp. (661.09M), less than Modular Medical, Inc. (68.50M), less than NeuroPace, Inc. (244.47M), greater than STRATA Skin Sciences, Inc. (22.16M), greater than Nemaura Medical Inc. (19.51M),

Build a custom stock screener for Nexalin Technology, Inc. (NXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nexalin Technology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nexalin Technology, Inc. (NXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nexalin Technology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.